CSL · 1 day ago
Marketing Summer Internship – 10 Weeks Hizentra
King of Prussia, PA
Internship
Onsite
InternCSL Behring is a global biotherapeutics leader dedicated to saving lives through innovative therapies. The Marketing Intern will support the HIZENTRA brand within the Immunoglobulin Franchise, gaining hands-on experience in marketing strategy and execution while collaborating with cross-functional teams.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Support the evolution of the SHARE (Starting Hizentra Administration with Resources and Education) program
Identify opportunities to improve the SHARE website experience and educational content for healthcare professionals
Assist in the development and execution of marketing strategies and tactics targeting Allied Health Professionals, including Nurse Practitioners, Registered Nurses, and Physician Assistants
Support marketing materials from concept through completion to drive commercial effectiveness
Collaborate cross‑functionally with internal stakeholders and external agency partners to support patient and HCP initiatives
Qualification
Required
Rising junior or senior pursuing a bachelor's degree in Marketing, Business, Communications, or a related field
Currently enrolled in an undergraduate marketing, communications, or related program
Strong written, verbal, and interpersonal communication skills
Highly organized with the ability to manage multiple priorities and deadlines
Demonstrated enthusiasm, curiosity, and confidence in a collaborative environment
Preferred
Interest in digital platforms, web content, or applications preferred
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Founded in 1916
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Leadership Team
Jeffrey Ball
Chief Sustainability Officer
Joy Linton
Strategic Advisor
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase